Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.</p>…”

Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.</p>…”

The percentage of studies that resulted in insect death increased over time. by Craig D. Perl (3326880)

Supplementary Material for: Decreasing Attacks and Improving Quality of Life through a Systematic Management Program for Patients with Hereditary Angioedema by Nunes F.L. (10223465)

“…<b><i>Results:</i></b> Mean number of attacks/month significantly decreased (95% credible interval [CrI] excluding 0) from 1.15 preintervention to 0.25 and 0.23, 8 and 14 months within intervention, with mean decreases of −0.89 (95% CrI: −1.21 to −0.58) and −0.92 (95% CrI: −1.22 to −0.60), respectively. …”

Enrichment analysis of genes from the significant MS module. by Lai Jiang (2401513)

Subjects:

<i>ogt-1; eel-1 +</i> Pan-neuronal OGT-1 have decreased sensitivity to electroshock and improved locomotion. by Nirthieca Suthakaran (11731101)

Starvation improves locomotory capacity and decreases the number of α-synuclein-YFP aggregates of transgenic <i>C. elegans</i> through LMP-1 dependent mechanism. by María Gallardo-Campos (22170919)

Compression modulus of improved red clay at 1600 kPa. by Quan Shen (37564)

Subjects:

Compressive strain of improved red clay at 1600 kPa. by Quan Shen (37564)

Subjects:

<i>e-lgp</i> curve of improved red clay. by Quan Shen (37564)

Subjects:

Visualization of heatmaps before and after improvement. by Junyan Wang (4738518)

Subjects:

Comparison of effects before and after improvement. by Junyan Wang (4738518)

Subjects:

The linearly decreasing convergence factor a. by Junhao Wei (6816803)

Platinum Twin and Triplet Drugs Improve Chemoimmunotherapy by Yuhao Hao (16938532)

“…The twin and triplet drugs exhibited significantly improved synergy with anti-PD-1 in a CT26 colorectal mouse tumor model. …”

Platinum Twin and Triplet Drugs Improve Chemoimmunotherapy by Yuhao Hao (16938532)

“…The twin and triplet drugs exhibited significantly improved synergy with anti-PD-1 in a CT26 colorectal mouse tumor model. …”

Platinum Twin and Triplet Drugs Improve Chemoimmunotherapy by Yuhao Hao (16938532)

“…The twin and triplet drugs exhibited significantly improved synergy with anti-PD-1 in a CT26 colorectal mouse tumor model. …”

Platinum Twin and Triplet Drugs Improve Chemoimmunotherapy by Yuhao Hao (16938532)

“…The twin and triplet drugs exhibited significantly improved synergy with anti-PD-1 in a CT26 colorectal mouse tumor model. …”

Comparison of the Non-healed but Improved DUs Based on Initial Wound Area Size in 2022 vs. 2023. by Heba Tallah Mohammed (2822432)

Subjects:

Comparison of the Non-healed but Improved PIs Based on Initial Wound Area Size in 2022 vs. 2023. by Heba Tallah Mohammed (2822432)

Subjects:

Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”